REVISION Flashcards
Cortisol is released in response to? Function?
- Released in response to stress and low blood-glucose concentration
- Increases blood sugar through gluconeogenesis
- Suppress the immune system (inflammation)
- Increases alertness and cognition
!GABA B agonist and antagonist
Ag: Baclofen – acts in spinal cord to reduce muscle spasm and treats alcholics
Antag: Saclofen
GHB (Gamma Hydroxy Butarate)receptors are ion/metab and has the effect of?
Metab, Gi, inhibits release of GABA and Glu
GHB is a partial agonist at?
GABA B receptors (some receptors have low, some have high affinity)
- Effect of GHB likely due to GABA synthesis
- GHB: At increasing concentrations: euphoria, anxiolysis, disinhibition
GABA C antagonist aids in
Inhibiting myopia development and facilitates learning and memory
Lead toxicity
a) Symptoms
b) Pathology
c) Recovery is accompanied by
d) Affects ____ and ___ transmission
a) Symptoms -lethargy, vomiting, irritability, loss of appetite & dizziness
progress to ataxia, reduced consciousness, coma & death
- “Footdrop” or “wristdrop ” due to segmental demyelination & axonal degeneration with Schwann cell degeneration (adults).
b) Pathology - edema of brain due to extravasation of fluid from capillaries, loss of neuronal cells and gliosis
c) Recovery - accompanied by epilepsy, mental retardation optic neuropathy and blindness
d) Glutamergic and dopaminergic
n-Hexane toxicity leads to?
Damages to neurofilaments and cross-linked cytoskeletal proteins, which aggregate in distal axon proximal to the nodes of Ranvier HENCE signal transmission disrupted
ROS hypothesis = Production of DA generates Fe3+ which reacts with ROS to switch on pathway that activates apoptosis - where do you get the Fe3+ from? ROS/
Fe 3+ - Tyrosine -> L-DOPA
ROS - Byproduct of ATP synthesis in mitochondria
!Inflammation is initiated by immune cells present in the tissue - mainly resident macrophages that express ___ that lead to inflammation. They also recognize ____ and ____
PRRs - pattern recognition receptors
PAMPs -pathogen-associated molecular patterns
DAMPS - danger-associated molecular patters released by injured cells
Does MyD88 play a role in neuronal survival following ischemia? Glial survival?
NO NO
A mouse lacking MyD88 is given a stroke and TLRs cannot work so we are not activating TLRs but why are we getting a bigger infarct?
The experiment is looking at neurons only but we need to look at BRAIN as a whole because there is BLOOD present - the vascular system changes during a stroke and influences the brain.
In vitro - it is detrimental
In vivo - it is protective following stroke
*Suggests that inhibiting TLR system in the blood, stops the beneficial response of these blood cells
What does the MyD88 KO lack?
Ability to get infiltrating cells there - you need TLR to get them to infarct as they are beneficial
What role does DJ-1 and PINK-1 play in PD?
Involved in mitochondria - mutations in these 2 genes lead to an increased amount of ROS = death
Why is MAOB inhibitor preferred over MAOA inhibitor?
MAOA inhibitor may cause hypertension
*Early use may delay disease progression by reducing formation of free radicals
2 suggestions to treat PD
5 years from now?
5-10 years from now?
10-20 years?
Adenosine A2a receptor antag make D2 more sensitive to Da and mGluR5 antag may allow higher dosages of L-DOPA
Deep brain stimulation (DBS) and optogentics
Genetics - find genes and target them, cell replacement therapy (induced pluripotent stem cells) - take a skin cell from patient and reprogram it then use another mix of genes to turn it into DA neuron (these cells avoid transplant rejection but also may be susceptible to the same disease process)
Donepezil (Aricept is brand name)
a) What is it?
b) Features - comp/non-comp, reversible/irreversible, half life?
c) Dosage?
d) Metabolised by?
e) Delays AD by how long?
f) Adverse effects?
a) Anticholinesterase used to treat AD
b) Non-comp and irreversible in terms of binding and have similar efficacy, with half life of 70 hours
c) Once a day 5 to 10 mg
d) Metab by cytochrome P450 isoenzymes CYP3A and CYP2D6
e) Delays deterioration by 6- 12 months
f) SE: Nausea, diarrhoea, anorexia, headache, insomnia, depression, drowsiness, dizziness, fatigue, sweating, tremor, muscle cramps